Dr. Michael Joner appointed as new CEO of CVPath Institute
Dr. Michael Joner has been delegated as the new CEO of CVPath Institute. The originator, president and medicinal chief of the CVPath Institute, Dr. Renu Virmani made this declaration only a couple of days before his formal arrangement, i.e. August 15, 2013. CVPath Institute is a main cardiovascular research organizer in India.
On the event of arrangement, Dr. Virmani said, “We are thrilled that Michael is joining CVPath in this key leadership role. He brings a new dimension to the Institute’s cardiovascular research services, given his dual perspective as a clinical scientist who is deeply engaged in patient care, as well as his proven leadership track record. As CEO, he will be responsible for propelling the Institute to the next level of success to ensure that it remains the premier cardiovascular research organization in an ever-changing, highly innovative and competitive field.”
Dr. joner has officially put in 2 years at CVPath Institute as the cardiovascular pathology individual somewhere around 2004 and 2006. He has an essential foundation in pathology, cardiovascular drug and innovation assessment. He went to Germany after that to finish his residency of interventional cardiology where he also filled in as the Head of the Preclinical Research at the German Heart Center in Munich. Dr. Michael Joner is a proficient scientist as he has a record of working with high-development restorative innovation organizations.
Dr. Joner is good to go to do a reversal to the CVPath institute. He said, “I am very excited to return to the CVPath Institute in this challenging and exciting new role and I am also delighted that Dr. Virmani will continue as CVPath’s Medical Director and board member. I have immense respect for her and her accomplishments, and I greatly enjoy our colleagueship.”
Dr. Virmani established CVPath Institute in 2005 as an NGO with the mission to direct fundamental and translational “bench to bedside” research.
ABOUT Dr. MICHAEL JONER
Dr. Joner joiner the CVPath Institute in August 2013 as its CEO. He has distinguished career in cardiovascular medicine, pathology, technology evaluation. He completed his training at the university of Wuerzbarg and spend 2004-2006 as a cardiovascular pathology fellow at a CVPath institute. After returning to Germany, since 2007 Dr. Joner has been head of the Preclinical Research at the German Heart Center in Munich where he has also completed his interventional cardiology Residency.